Literature DB >> 23454361

Crystal structure analysis of human Sirt2 and its ADP-ribose complex.

Sébastien Moniot1, Mike Schutkowski, Clemens Steegborn.   

Abstract

Sirtuins are NAD(+)-dependent protein deacetylases that regulate metabolism and aging-related processes. Sirt2 is the only cytoplasmic isoform among the seven mamalian Sirtuins (Sirt1-7) and structural information concerning this isoform is limited. We crystallized Sirt2 in complex with a product analog, ADP-ribose, and solved this first crystal structure of a Sirt2 ligand complex at 2.3Å resolution. Additionally, we re-refined the structure of the Sirt2 apoform and analyzed the conformational changes associated with ligand binding to derive insights into the dynamics of the enzyme. Our analyses also provide information on Sirt2 peptide substrate binding and structural states of a Sirt2-specific protein region, and our insights and the novel Sirt2 crystal form provide helpful tools for the development of Sirt2 specific inhibitors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454361     DOI: 10.1016/j.jsb.2013.02.012

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  24 in total

1.  Propofol inhibits SIRT2 deacetylase through a conformation-specific, allosteric site.

Authors:  Brian P Weiser; Roderic G Eckenhoff
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

Review 2.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

Review 3.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

4.  Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.

Authors:  Jessica L Feldman; Kristin E Dittenhafer-Reed; Norio Kudo; Julie N Thelen; Akihiro Ito; Minoru Yoshida; John M Denu
Journal:  Biochemistry       Date:  2015-05-04       Impact factor: 3.162

5.  Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.

Authors:  Norio Kudo; Akihiro Ito; Mayumi Arata; Akiko Nakata; Minoru Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

6.  Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.

Authors:  Andreas S Madsen; Christian Andersen; Mohammad Daoud; Kristin A Anderson; Jonas S Laursen; Saswati Chakladar; Frank K Huynh; Ana R Colaço; Donald S Backos; Peter Fristrup; Matthew D Hirschey; Christian A Olsen
Journal:  J Biol Chem       Date:  2016-02-09       Impact factor: 5.157

7.  Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.

Authors:  David Bi; Jie Yang; Jun Young Hong; Prashit Parikh; Nicole Hinds; Joseph Infanti; Hening Lin; Brian P Weiser
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

8.  Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson's disease.

Authors:  Amrendra Pratap Singh; Lokesh Nigam; Yudhishthir Yadav; Shashank Shekhar; Naidu Subbarao; Sharmistha Dey
Journal:  Mol Divers       Date:  2020-06-26       Impact factor: 2.943

Review 9.  Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders.

Authors:  Xiuqi Chen; Wenmei Lu; Danhong Wu
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

10.  Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.

Authors:  Tobias Rumpf; Stefan Gerhardt; Oliver Einsle; Manfred Jung
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-11-18       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.